Occupation or Discipline – Page 21

The Transformative Future of Specialist Distribution: Adaptive Strategies and Technological Innovations

2 years ago talkbio0Tagged **Last-Mile Solutions**:, Adaptive Strategies, Artificial Intelligence, Automation, Data Integration, Global Expansion, Hospital specialist, Smart Distribution Centers, Spatial Distribution, Technological Innovations, trends qualifier, Virtual Distribution

Specialist Distribution, Future Trends, Adaptive Strategies, Technological Innovations, Automation, Artificial Intelligence, Last-Mile Solutions, Virtual Distribution, Data Integration, Global Expansion, Smart Distribution Centers

Fujifilm Diosynth Announces $1.2B Expansion in North Carolina, Aiming to Employ 1,400

2 years ago talkbio0Tagged Biopharmaceutical manufacturing, Biotechnology, CDMO facility, end-to-end cell culture, expansion, Fujifilm, Holly Springs, Investments, Japanese language, North Carolina, Occupations

Fujifilm Diosynth Biotechnologies, $1.2 billion expansion, North Carolina, Holly Springs, 1/400 jobs, Biopharmaceutical manufacturing, End-to-end cell culture CDMO facility, Japanese investment

AstraZeneca Commits £650M Expansion for UK Vaccine Hub and Research Campus

2 years ago talkbio0Tagged AstraZeneca, Cambridge/, Economic Growth, England, Environment, Government support, Investments, Life sciences sector, Occupations, operationally, pandemic preparedness, public health protection, Renewable Energy, research, Research and Development, Speke/ Liverpool, Surgical construction, Taxes, UK vaccine

AstraZeneca, £650 million investment, UK vaccine hub, Speke/ Liverpool, Renewable energy, Operationally net-zero facility, Research and Development (R&D) campus, Cambridge/ England, Job creation, Pandemic preparedness, Public health protection, Economic growth, Government support, Tax environment, Life sciences sector

NICE Rejects Coverage for AstraZeneca and Daiichi Sankyo’s Breast Cancer Drug Enhertu Due to Cost-Effectiveness Concerns

2 years ago talkbio0Tagged AstraZeneca, Cost Effectiveness, Coverage rejection, Daiichi Sankyo, Enhertu, Health Services, National, Malignant neoplasm of breast, Nitroglycerin/Sodium Citrate/Ethanol Solution, Technology

NICE, Enhertu, AstraZeneca, Daiichi Sankyo, Breast cancer, Cost-effectiveness, Coverage rejection, Technology Appraisal, National Health Service (NHS)